medline.ch Gastroenterologie Pankreas Neoplasie

	Gut Microbiota: Its Potential Roles in Pancreatic Cancer. Front Cell Infect Microbiol Li Q, Jin M, Liu Y, Jin L. PMID: 33117731 [PubMed - in process]
	Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies. Front Oncol Xu R, Yang J, Ren B, Wang H, Yang G, Chen Y, You L, Zhao Y. PMID: 33117704 [PubMed]
	Clinical Significance of Glucose to Lymphocyte Ratio (GLR) as a Prognostic Marker for Patients With Pancreatic Cancer. Front Oncol Zhong A, Cheng CS, Kai J, Lu R, Guo L. PMID: 33117673 [PubMed]
	Conversion Therapy for Advanced Pancreatic Cancer: The Case Series and Literature Review. Front Pharmacol Wang M, Xu Y, Yang M, Jiang D, Chen Y, Jiang J, Chen Z, Yang L, Huang D. PMID: 33117173 [PubMed]
	Early Diagnosis of Pancreatic Cancer: The Key for Survival. Diagnostics (Basel) Gheorghe G, Bungau S, Ilie M, Behl T, Vesa CM, Brisc C, Bacalbasa N, Turi V, Costache RS, Diaconu CC. PMID: 33114412 [PubMed]
	Pancreatic Cancer (PDAC): Introduction of Evidence-Based Complementary Measures into Integrative Clinical Management. Cancers (Basel) Jentzsch V, Davis JAA, Djamgoz MBA. PMID: 33114159 [PubMed]
	Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic Cancer. Cells Geismann C, Arlt A. PMID: 33113836 [PubMed - in process]
	New Hepatic Resection Criteria for Intermediate-Stage Hepatocellular Carcinoma Can Improve Long-Term Survival: A Retrospective, Multicenter Collaborative Study. Asian Pac J Cancer Prev Iida H, Kaibori M, Hirokawa F, Inoue Y, Ueno M, Matsui K, Ishizaki M, Tanaka S, Takemura S, Nomi T, Hokutou D, Noda T, Eguchi H, Nakai T, Maehira H, Mori H, Tani M, Kubo S. PMID: 33112547 [PubMed - in process]
	Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting. Clin Cancer Res Morris JS, Luthra R, Liu Y, Duose DY, Lee W, Reddy NG, Windham J, Chen H, Tong Z, Zhang B, Wei W, Ganiraju M, Broom BM, Alvarez HA, Mejia A, Veeranki O, Routbort MJ, Morris VK, Overman MJ, Menter D, Katkhuda R, Wistuba II, Davis JS, Kopetz S, Maru DM. PMID: 33109741 [PubMed - as supplied by publisher]
	Prognostic and clinicopathological significance of pretreatment mean platelet volume in cancer: a meta-analysis. BMJ Open Chen X, Li J, Zhang X, Liu Y, Wu J, Li Y, Cui X, Jiang X. PMID: 33109647 [PubMed - in process]
	Prolactin: A hormone with diverse functions from mammary gland development to cancer metastasis. Semin Cell Dev Biol Karayazi At, Govindrajan N, Lopetegui-González I, Shemanko CS. PMID: 33109441 [PubMed - as supplied by publisher]
	Cachexia, dietetic consultation, and survival in patients with pancreatic and periampullary cancer: A multicenter cohort study. Cancer Med Latenstein AEJ, Dijksterhuis WPM, Mackay TM, Beijer S, van Eijck CHJ, de Hingh IHJT, Molenaar IQ, van Oijen MGH, van Santvoort HC, de van der Schueren MAE, de Vos-Geelen J, de Vries JHM, Wilmink JW, Besselink MG, van Laarhoven HWM, Dutch Pancreatic Cancer Group.. PMID: 33107709 [PubMed - as supplied by publisher]
	Metformin and Gastrointestinal Cancer Development in Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea. Clin Transl Gastroenterol You JH, Song SO, Kang MJ, Cho YY, Kim SW, Suh SH, Lee S, Lee YH, Lee BW. PMID: 33105165 [PubMed - in process]
	ASO Author Reflections: The Impact of Residential Segregation on Pancreatic Cancer Diagnosis, Treatment, and Mortality. Ann Surg Oncol Poulson MR, Blanco BA, Sachs TE. PMID: 33103214 [PubMed - as supplied by publisher]
	Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma. Front Oncol Hu X, Bao M, Huang J, Zhou L, Zheng S. PMID: 33102213 [PubMed]
	Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma. Exp Hematol Oncol Gao HL, Wang WQ, Yu XJ, Liu L. PMID: 33101770 [PubMed]
	Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer. Br J Cancer Willenbrock F, Cox CM, Parkes EE, Wilhelm-Benartzi CS, Abraham AG, Owens R, Sabbagh A, Jones CM, Hughes DLI, Maughan T, Hurt CN, O'Neill EE, Mukherjee S. PMID: 33100327 [PubMed - as supplied by publisher]
	A Chinese Retrospective Multicenter Study of First-Line Chemotherapy for Advanced Pancreatic Cancer. Med Sci Monit Cui H, Guan J, Deng G, Yuan J, Lou C, Zhang W, Zhou A, Zhang Y, Zhou J, Dai G. PMID: 33100319 [PubMed - in process]
	nal-IRI+5-FU/LV versus 5-FU/LV in post-gemcitabine metastatic pancreatic cancer: Randomized phase 2 trial in Japanese patients. Cancer Med Ueno M, Nakamori S, Sugimori K, Kanai M, Ikeda M, Ozaka M, Furukawa M, Okusaka T, Kawabe K, Furuse J, Komatsu Y, Ishii H, Sato A, Shimizu S, Chugh P, Tang R, Ioka T. PMID: 33099898 [PubMed - as supplied by publisher]
	Phase 1 study of Gemcitabine/Nab-paclitaxel/S-1 in patients with unresectable pancreatic cancer (GeNeS1S trial). Cancer Chemother Pharmacol Sai S, Toyoda M, Tobimatsu K, Satake H, Yasui H, Kimbara S, Koyama T, Fujishima Y, Imamura Y, Funakoshi Y, Kiyota N, Toyama H, Kodama Y, Minami H. PMID: 33098471 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 39317

Seite 1 von 1966

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung